You have 9 free searches left this month | for more free features.

Protease Inhibitors

Showing 1 - 25 of 4,930

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    HIV Trial in United States (Ritonavir, Saquinavir, Methadone HCl)

    Completed
    • HIV Infections
    • San Francisco, California
    • +6 more
    Oct 27, 2021

    HIV Patients Trial in France (No intervention)

    Completed
    • HIV Patients
    • No intervention
    • Créteil, France
    • +5 more
    Jul 30, 2021

    HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)

    Completed
    • HIV Infections
    • +2 more
    • Indinavir sulfate
    • +3 more
    • San Francisco, California
    • +8 more
    Oct 28, 2021

    HIV-1-infection Trial in Kenya (Dolutegravir)

    Completed
    • HIV-1-infection
    • Kiambu, Kenya
    • +3 more
    Jan 26, 2022

    HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)

    Completed
    • HIV Infections
    • Pravastatin sodium
    • +5 more
    • Los Angeles, California
    • +12 more
    Oct 27, 2021

    HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

    Active, not recruiting
    • HIV-1 Infection
    • Doravirine, Tenofovir, Lamivudine
    • +4 more
    • (no location specified)
    Sep 2, 2022

    HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

    Recruiting
    • HIV-1-infection
    • Multi-Antiviral Resistance
    • REGISTER CREATION
    • Milan, MI, Italy
      Ospedale San Raffaele
    Dec 22, 2021

    HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

    Recruiting
    • HIV I Infection
    • Adiposity
    • Frequently sampled glucose tolerance testing
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 15, 2022

    HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +12 more
    Oct 28, 2021

    HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

    Active, not recruiting
    • HIV-1-infection
    • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
    • Antwerp, Belgium
    • +28 more
    May 23, 2022

    HIV, Pregnancy Trial in Worldwide (Lamivudine, Lamivudine/Zidovudine, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Pregnancy
    • Los Angeles, California
    • +48 more
    Oct 28, 2021

    HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +22 more
    Oct 28, 2021

    HIV Trial in Aurora (Atazanavir)

    Completed
    • HIV
    • Aurora, Colorado
      University of Colorado Denver and Health Sciences Center
    Oct 31, 2019

    HIV-1 Infection Trial in Badalona (Isentress® (Raltegravir, 400 mg every 12 hours), Isentress® (Raltegravir, 400 every 12

    Completed
    • HIV-1 Infection
    • Isentress® (Raltegravir, 400 mg every 12 hours)
    • Isentress® (Raltegravir, 400 every 12 hours)
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol Hospital
    Nov 11, 2019

    HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Amprenavir)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +7 more
    • Los Angeles, California
    • +44 more
    Oct 27, 2021

    HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Nevirapine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +44 more
    Oct 27, 2021

    HIV, Fenofibrate, Protease Inhibitors Trial run by the CC (Fenofibrate, Ritonavir, Lopinavir/Ritonavir)

    Completed
    • HIV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 6, 2019

    COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )

    Recruiting
    • COVID-19
    • Shionogi Protease Inhibitor (S-217622)
    • placebo
    • Minneapolis, Minnesota
      University of Minnesota
    Jan 12, 2023

    Coronary Artery Disease, Hiv Trial (Biktarvy)

    Unknown status
    • Coronary Artery Disease
    • Hiv
    • (no location specified)
    Sep 27, 2019

    HIV Trial in United States (Indinavir sulfate, Saquinavir)

    Completed
    • HIV Infections
    • Palo Alto, California
    • +15 more
    Oct 27, 2021

    HIV Trial in Spain (Nevirapine, Efavirenz, Indinavir/ritonavir)

    Completed
    • HIV Infections
    • Badalona, Barcelona, Spain
    • +5 more
    Dec 3, 2019

    HIV Trial in United States (Ritonavir, Nelfinavir mesylate, Levocarnitine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +44 more
    Oct 27, 2021

    Malaria, HIV Trial in Tororo (Lopinavir/ritonavir, Efavirenz, Zidovudine)

    Completed
    • Malaria
    • HIV Infections
    • Tororo, Uganda
      Tororo District Hospital
    Apr 19, 2019